Dive Into Dollar Tr...
Health Care: Drugs
Cerus Corporation (CERS: NASDAQ)
$5.37 -0.11 | -2.01%
05/20/13 - 04:00 PM ET
Company Income Statement
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Sales | 36.79M | 33.04M | 23.11M | 17.98M |
| Cost of Sales | 20.07M | 17.82M | 11.27M | 11.66M |
| Gross Operating Profit | 16.71M | 15.23M | 11.84M | 6.32M |
| Selling, General, and Administrative Expenses | 25.66M | 23.05M | 21.58M | 21.87M |
| Research & Development | 7.60M | 7.18M | 5.20M | 6.37M |
| Operating Income before D & A (EBITDA) | -16.56M | -15.00M | -14.93M | -21.92M |
| Depreciation & Amortization | 744.00K | 922.00K | 845.00K | 915.00K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income - Net | 2.18M | -94.00K | -446.00K | -155.00K |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | -15.12M | -16.02M | -16.22M | -23.83M |
| Interest Expense | 551.00K | 964.00K | 689.00K | 302.00K |
| Pre-Tax Income | -15.68M | -16.98M | -16.91M | -24.14M |
| Income Taxes | 242.00K | 0.00 | 0.00 | 0.00 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | -15.92M | -16.98M | -16.91M | -24.14M |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | -15.92M | -16.98M | -16.91M | -24.14M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | -15.92M | -16.98M | -16.91M | -24.14M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-15.92M | -16.98M | -16.91M | -23.29M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | -15.92M | -16.98M | -16.91M | -24.14M |
| Basic EPS from Continuing Ops. | -0.29 | -0.35 | -0.42 | -0.69 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | -0.29 | -0.35 | -0.42 | -0.69 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | -0.29 | -0.35 | -0.42 | -0.69 |
| Basic Normalized Net Income/Share | -0.29 | -0.35 | -0.42 | -0.67 |
| EPS fr Continuing Ops. | -0.33 | -0.35 | -0.42 | -0.69 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | -0.33 | -0.35 | -0.42 | -0.69 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | -0.33 | -0.35 | -0.42 | -0.69 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-0.33 | -0.35 | -0.42 | -0.67 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with CERS
- Portfolio NameUser Type
- ContributorBreakout Stocks Of The Week...
- ContributorBreakout Stocks Of The Week...
- UserRASHID 1
- Contributor5 Bargain Biotech Stocks
- UserImagine!
- UserSUPRATRADE - 8 Hot Stocks t...
- UserShake & Bakkke
- Sharespy
- Usermoneymag7 Portfolio 1
- Useriornhorse
Latest CERS Headlines from TheStreet
- 5 Stocks Poised for Breakouts 09.28.12 | 01:09 pm
- 5 Stocks Poised for Breakouts 07.13.12 | 12:07 pm
- Insiders Trading CERS, IL, MDCA, UA 05.09.11 | 08:05 am
- Cerus Stock Gaps Down On Today's Open (CERS) 03.04.11 | 09:03 am
- 5 Bargain Biotech Stocks 01.13.11 | 05:01 pm
- Jones Soda, Callon Petroleum: Early Volume Plays 03.09.10 | 09:03 am
- China BAK, Euro Tech: Early Volume Plays 02.09.10 | 10:02 am
- Biotech Stock Mailbag: FDA Playbook 11.20.09 | 06:11 am
- Playboy, Helicos: Early Volume Plays 11.17.09 | 09:11 am
- Friday's Health Winners & Losers 05.02.08 | 03:05 pm
Press Releases for CERS
- Cerus Signs INTERCEPT Platelet Agreements With Two Key Blood Component Suppliers In Germany And Austria - Business Wire 03.15.13 | 08:03 am
- Cerus Prices Public Offering Of Common Stock - Business Wire 03.14.13 | 09:03 am
- Cerus Corporation Reports Fourth Quarter And Year-End 2012 Results - Business Wire 02.28.13 | 04:02 pm
- Cerus To Present At The Cowen And Company 33rd Annual Health Care Conference On March 6, 2013 - Business Wire 02.27.13 | 08:02 am
- Cerus To Release Fourth Quarter And Year-End 2012 Results On February 28, 2013 - Business Wire 02.14.13 | 08:02 am
- Cerus Announces FDA Agreement On Modular Premarket Approval Application (PMA) Submission Process For INTERCEPT Plasma - Business Wire 12.13.12 | 08:12 am
- Cerus Signs Agreement With Swiss Red Cross For Initial Deployment Of The INTERCEPT Blood System For Plasma - Business Wire 12.04.12 | 08:12 am
- Cerus To Present At The Piper Jaffray Healthcare Conference On November 28, 2012 - Business Wire 11.21.12 | 08:11 am
- Cerus To Present At The Stephens Fall Investment Conference On November 14, 2012 - Business Wire 11.08.12 | 09:11 am
- Cerus To Present At The Lazard Capital Markets 9th Annual Healthcare Conference On November 14, 2012 - Business Wire 11.08.12 | 08:11 am
Partner Headlines for CERS
- After Hours Most Active for Mar 1, 2013 : CERS, SIRI, ABT, SBGL, ABBV, VOD, BAC, NOK, QQQ, AMD, INTC, HOLX - NASDAQ 03.01.13 | 09:03 pm
- Low-Priced Biotech Stocks With Insider Buying - Seeking Alpha 03.18.11 | 06:03 pm
- Company News for March 07, 2011 - Corporate Summary - Zacks 03.07.11 | 10:03 am
- UPDATE 1-Cerus to regain Asian rights for blood safety system - Reuters 08.24.10 | 05:08 pm
- Cerus: An Unknown Gem That's Primed for a Boost - Seeking Alpha 05.18.10 | 02:05 pm
- Tengion's IPO Comes In Well Below Initial Range: Biotech's Latest Deals, Financings - SeekingAlpha.com 04.11.10 | 08:04 am
- The Return of Buy and Hold? - SeekingAlpha.com 04.06.10 | 10:04 am
- 25 Momentum Stocks for Tuesday - SeekingAlpha.com 04.06.10 | 03:04 am
- Weekly Street Sentiment: Market Continues Up, But Sell-Side Sentiment Eases Lower Again - SeekingAlpha.com 04.05.10 | 12:04 am
- UPDATE 1-Cerus in development deal for blood safety system - Reuters 02.09.10 | 01:02 pm
